stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Operating cash flow
DENTSPLY SIRONA Inc.'s operating cash flow for fiscal 2025 was $235.0M, down 49.0% from $461.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $272.0M. Over the past ten years it has ranged from $235.0M (fiscal 2025) to $657.0M (fiscal 2021) — the current reading is the lowest in ten years. DENTSPLY SIRONA Inc. ranks 18th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $235.0M | (49.02%) |
| FY2024 | $461.0M | 22.28% |
| FY2023 | $377.0M | (27.08%) |
| FY2022 | $517.0M | (21.31%) |
| FY2021 | $657.0M | 1.23% |
| FY2020 | $649.0M | 1.56% |
| FY2019 | $639.0M | 27.80% |
| FY2018 | $500.0M | (16.93%) |
| FY2017 | $601.9M | 6.83% |
| FY2016 | $563.4M | 13.27% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $32.0M | (67.68%) |
| Jun 2026 | $99.0M | 147.50% |
| Mar 2026 | $40.0M | (60.40%) |
| Dec 2025 | $101.0M | 27.85% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | $289.2M |
| XRAY DENTSPLY SIRONA Inc. | $272.0M |
| WRBY Warby Parker Inc. compare | $102.1M |
| LMAT LeMaitre Vascular, Inc. compare | $76.2M |
| ATRC AtriCure, Inc. compare | $68.5M |
| AZTA Azenta, Inc. compare | $38.0M |
| STAA STAAR Surgical Company compare | $21.4M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$87.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement